Advertisement
  • A Switch From Intravenous to Oral Chemo?

    Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.

    by Ashley P. Taylor

  • Avoiding Unnecessary Lymph Node Biopsy

    A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed.

    by Cheryl Platzman Weinstock

  • December 6: The Week in Cancer News

    A study suggests an association between hair dye use and breast cancer, and the U.S. Food and Drug Administration adds a new indication for an immunotherapy-chemotherapy combination.

    by Kate Yandell

  • Encouraging Beneficial Gut Microbes

    Nutritional epidemiologist Carrie Daniel-MacDougall discusses research suggesting that what patients eat affects their gut microbes—and could influence cancer immunotherapy response.

    by Anna Azvolinsky

  • Cancer Takes an Unequal Toll on Employment

    In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment.

    by Pamela Rafalow Grossman

  • Cancer and Credit

    The financial burden of a cancer diagnosis can lower a patient's credit score.

    by Shelly Rosenfeld

  • November 22: The Week in Cancer News

    Data from Northern Ireland suggest a fifth of cancer diagnoses are made in the emergency department, and a study investigates how the nervous system might be harnessed for cancer treatment.

    by Bradley Jones

  • November 15: The Week in Cancer News

    A study suggests the rate of melanoma diagnoses in adolescents and young adults is falling, and a health care reporter writes about the many difficult decisions she had to make after her cancer diagnosis.

    by Kate Yandell

  • Treating Fear of Recurrence

    Cognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say.

    by Jon Kelvey

  • November 8: The Week in Cancer News

    Some oncologists do not discuss the costs of genomic testing and resulting treatments with their patients, and preliminary results indicate that a cancer therapy using the CRISPR gene-editing technique is safe.

    by Kate Yandell